SCCL
TMO icon

Split Creek Capital LLC’s Thermo Fisher Scientific TMO Stock Holding History

Split Creek Capital LLC’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$439K Sell
875
-1
-0.1% -$480 0.41% 74
2026
Q1 		$431K Buy
876
+1
+0.1% +$543 0.45% 69
2025
Q4 		$507K Buy
+875
New +$495K 0.54% 57

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Split Creek Capital LLC's TMO Position: Q2 2026 in Review

Split Creek Capital LLC reduced its Thermo Fisher Scientific (TMO) stake by 0.11% in Q2 2026, selling an estimated $480 and leaving 875 shares worth $439K. The position accounts for 0.41% of the portfolio, ranked #74.

Split Creek Capital LLC first reported a position in TMO in Q4 2025 and has held it in 3 quarters since. The position peaked at $507K in Q4 2025. 2,639 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Split Creek Capital LLC held 875 shares of Thermo Fisher Scientific worth $439K as of Q2 2026.
  • Split Creek Capital LLC sold 1 Thermo Fisher Scientific share in Q2 2026, an estimated $480.
  • Thermo Fisher Scientific made up 0.41% of Split Creek Capital LLC's portfolio in Q2 2026, its #74 holding.
  • Split Creek Capital LLC first reported a position in Thermo Fisher Scientific in Q4 2025 and has held it in 3 quarters since.
  • Split Creek Capital LLC's Thermo Fisher Scientific position peaked at $507K in Q4 2025.
  • 2,639 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Split Creek Capital LLC's 13F filing for Q2 2026, filed 23 Oct 2026.